{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:51:31Z","timestamp":1790754691629,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/cmi.2016.47","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T08:42:46Z","timestamp":1474879366000},"page":"842-849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus"],"prefix":"10.1038","volume":"14","author":[{"given":"Li-dan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-ni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-wen","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-yun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-tao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"key":"BFcmi201647_CR1","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","volume":"165","author":"M Odendahl","year":"2000","unstructured":"Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000; 165: 5970\u20135979.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA . Systemic lupus erythematosus. N Engl J Med 2008; 358: 929\u2013939.","journal-title":"N Engl J Med"},{"key":"BFcmi201647_CR3","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","volume":"95","author":"A Peled","year":"2000","unstructured":"Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice. Blood 2000; 95: 3289\u20133296.","journal-title":"Blood"},{"key":"BFcmi201647_CR4","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.4049\/jimmunol.164.10.5010","volume":"164","author":"T Nanki","year":"2000","unstructured":"Nanki T, Lipsky PE . Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 2000; 164: 5010\u20135014.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR5","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1182\/blood.V94.9.2990.421k36_2990_2998","volume":"94","author":"M Honczarenko","year":"1999","unstructured":"Honczarenko M, Douglas RS, Mathias C, Lee B, Ratajczak MZ, Silberstein LE . SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 1999; 94: 2990\u20132998.","journal-title":"Blood"},{"key":"BFcmi201647_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","volume":"29","author":"X Sun","year":"2010","unstructured":"Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J et al. CXCL12 \/ CXCR4 \/ CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 2010; 29: 709\u2013722.","journal-title":"Cancer Metastasis Rev"},{"key":"BFcmi201647_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0014-5793(98)00359-7","volume":"426","author":"A Caruz","year":"1998","unstructured":"Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL et al. Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett 1998; 426: 271\u2013278.","journal-title":"FEBS Lett"},{"key":"BFcmi201647_CR8","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.4049\/jimmunol.0801920","volume":"182","author":"A Wang","year":"2009","unstructured":"Wang A, Fairhurst AM, Tus K, Subramanian S, Liu Y, Lin F et al. CXCR4\/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol 2009; 182: 4448\u20134458.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni1100","volume":"5","author":"CD Allen","year":"2004","unstructured":"Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004; 5: 943\u2013952.","journal-title":"Nat Immunol"},{"key":"BFcmi201647_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1084\/jem.194.1.45","volume":"194","author":"DC Hargreaves","year":"2001","unstructured":"Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001; 194: 45\u201356.","journal-title":"J Exp Med"},{"key":"BFcmi201647_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/31261","volume":"393","author":"K Tachibana","year":"1998","unstructured":"Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998; 393: 591\u2013594.","journal-title":"Nature"},{"key":"BFcmi201647_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/31269","volume":"393","author":"YR Zou","year":"1998","unstructured":"Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR . Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595\u2013599.","journal-title":"Nature"},{"key":"BFcmi201647_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","volume":"25","author":"T Sugiyama","year":"2006","unstructured":"Sugiyama T, Kohara H, Noda M, Nagasawa T . Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25: 977\u2013988.","journal-title":"Immunity"},{"key":"BFcmi201647_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/382635a0","volume":"382","author":"T Nagasawa","year":"1996","unstructured":"Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF\/SDF-1. Nature 1996; 382: 635\u2013638.","journal-title":"Nature"},{"key":"BFcmi201647_CR15","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1517\/14728220903196761","volume":"13","author":"BF Chong","year":"2009","unstructured":"Chong BF, Mohan C . Targeting the CXCR4\/CXCL12 axis in systemic lupus erythematosus. Expert Opin Ther Targets 2009; 13: 1147\u20131153.","journal-title":"Expert Opin Ther Targets"},{"key":"BFcmi201647_CR16","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.27685","volume":"62","author":"A Wang","year":"2010","unstructured":"Wang A, Guilpain P, Chong BF, Chouzenoux S, Guillevin L, Du Y et al. Dysregulated expression of CXCR4\/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum 2010; 62: 3436\u20133446.","journal-title":"Arthritis Rheum"},{"key":"BFcmi201647_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1479-5876-10-251","volume":"10","author":"V Biajoux","year":"2012","unstructured":"Biajoux V, Bignon A, Freitas C, Martinez V, Thelen M, Lima G et al. Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus. J Transl Med 2012; 10: 251.","journal-title":"J Transl Med"},{"key":"BFcmi201647_CR18","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.4049\/jimmunol.170.6.3392","volume":"170","author":"K Balabanian","year":"2003","unstructured":"Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A et al. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J Immunol 2003; 170: 3392\u20133400.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR19","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1111\/j.1523-1755.2005.00275.x","volume":"67","author":"F Togel","year":"2005","unstructured":"Togel F, Isaac J, Hu Z, Weiss K, Westenfelder C . Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772\u20131784.","journal-title":"Kidney Int"},{"key":"BFcmi201647_CR20","doi-asserted-by":"publisher","first-page":"e0125340","DOI":"10.1371\/journal.pone.0125340","volume":"10","author":"G Badr","year":"2015","unstructured":"Badr G, Sayed A, Abdel-Maksoud MA, Mohamed AO, El-Amir A, Abdel-Ghaffar FA et al. Infection of female BWF1 lupus mice with malaria parasite attenuates B cell autoreactivity by modulating the CXCL12\/CXCR4 axis and its downstream signals PI3K\/AKT, NFkappaB and ERK. PLoS One 2015; 10: e0125340.","journal-title":"PLoS One"},{"key":"BFcmi201647_CR21","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.4049\/jimmunol.1003401","volume":"186","author":"N Yoshida","year":"2011","unstructured":"Yoshida N, Kitayama D, Arima M, Sakamoto A, Inamine A, Watanabe-Takano H et al. CXCR4 expression on activated B cells is downregulated by CD63 and IL-21. J Immunol 2011; 186: 2800\u20132808.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1084\/jem.189.9.1461","volume":"189","author":"R Guinamard","year":"1999","unstructured":"Guinamard R, Signoret N, Ishiai M, Marsh M, Kurosaki T, Ravetch JV . B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. J Exp Med 1999; 189: 1461\u20131466.","journal-title":"J Exp Med"},{"key":"BFcmi201647_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1196\/annals.1423.063","volume":"1110","author":"JA Bubier","year":"2007","unstructured":"Bubier JA, Bennett SM, Sproule TJ, Lyons BL, Olland S, Young DA et al. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Ann N Y Acad Sci 2007; 1110: 590\u2013601.","journal-title":"Ann N Y Acad Sci"},{"key":"BFcmi201647_CR24","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","volume":"173","author":"K Ozaki","year":"2004","unstructured":"Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004; 173: 5361\u20135371.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cmi.2014.58","volume":"12","author":"XM Deng","year":"2015","unstructured":"Deng XM, Yan SX, Wei W . IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation. Cell Mol Immunol 2015; 12: 31\u201339.","journal-title":"Cell Mol Immunol"},{"key":"BFcmi201647_CR26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/jcmm.12795","volume":"20","author":"W Bing","year":"2016","unstructured":"Bing W, Pang X, Qu Q, Bai X, Yang W, Bi Y et al. Simvastatin improves the homing of BMSCs via the PI3K\/AKT\/miR-9 pathway. J Cell Mol Med 2016; 20: 949\u2013961.","journal-title":"J Cell Mol Med"},{"key":"BFcmi201647_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.gene.2014.01.012","volume":"538","author":"Y Lan","year":"2014","unstructured":"Lan Y, Luo B, Wang JL, Jiang YW, Wei YS . The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus. Gene 2014; 538: 94\u201398.","journal-title":"Gene"},{"key":"BFcmi201647_CR28","doi-asserted-by":"publisher","first-page":"246ra99","DOI":"10.1126\/scitranslmed.3009131","volume":"6","author":"XN Wu","year":"2014","unstructured":"Wu XN, Ye YX, Niu JW, Li Y, Li X, You X et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med 2014; 6: 246ra99.","journal-title":"Sci Transl Med"},{"key":"BFcmi201647_CR29","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1096\/fasebj.13.13.1699","volume":"13","author":"AJ Vila-Coro","year":"1999","unstructured":"Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez AC, Mellado M . The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK\/STAT pathway. FASEB J 1999; 13: 1699\u20131710.","journal-title":"FASEB J"},{"key":"BFcmi201647_CR30","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.4049\/jimmunol.0901690","volume":"183","author":"TD Chan","year":"2009","unstructured":"Chan TD, Gatto D, Wood K, Camidge T, Basten A, Brink R . Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J Immunol 2009; 183: 3139\u20133149.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR31","first-page":"863","volume":"33","author":"H Hanaoka","year":"2015","unstructured":"Hanaoka H, Okazaki Y, Hashiguchi A, Yasuoka H, Takeuchi T, Kuwana M . Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus. Clin Exp Rheumatol 2015; 33: 863\u2013870.","journal-title":"Clin Exp Rheumatol"},{"key":"BFcmi201647_CR32","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","volume":"179","author":"S Kuchen","year":"2007","unstructured":"Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 2007; 179: 5886\u20135896.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR33","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.4049\/jimmunol.177.12.8381","volume":"177","author":"D Konforte","year":"2006","unstructured":"Konforte D, Paige CJ . Identification of cellular intermediates and molecular pathways induced by IL-21 in human B cells. J Immunol 2006; 177: 8381\u20138392.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20091706","volume":"207","author":"DT Avery","year":"2010","unstructured":"Avery DT, Deenick EK, Ma CS, Suryani S, Simpson N, Chew GY et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010; 207: 155\u2013171.","journal-title":"J Exp Med"},{"key":"BFcmi201647_CR35","first-page":"609","volume":"16","author":"H Mitoma","year":"2005","unstructured":"Mitoma H, Horiuchi T, Kimoto Y, Tsukamoto H, Uchino A, Tamimoto Y et al. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Int J Mol Med 2005; 16: 609\u2013615.","journal-title":"Int J Mol Med"},{"key":"BFcmi201647_CR36","first-page":"495934","volume":"2012","author":"S Garcia-Rodriguez","year":"2012","unstructured":"Garcia-Rodriguez S, Callejas-Rubio JL, Ortego-Centeno N, Zumaquero E, R\u00edos-Fernandez R, Arias-Santiago S et al. Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients. Mediators Inflamm 2012; 2012: 495934.","journal-title":"Mediators Inflamm"},{"key":"BFcmi201647_CR37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/ndt\/gfq496","volume":"26","author":"K Stylianou","year":"2011","unstructured":"Stylianou K, Petrakis I, Mavroeidi V, Stratakis S, Vardaki E, Perakis K et al. The PI3K\/Akt\/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. Nephrol Dial Transplant 2011; 26: 498\u2013508.","journal-title":"Nephrol Dial Transplant"},{"key":"BFcmi201647_CR38","doi-asserted-by":"publisher","first-page":"17408","DOI":"10.1074\/jbc.M414219200","volume":"280","author":"M Moriguchi","year":"2005","unstructured":"Moriguchi M, Hissong BD, Gadina M, Yamaoka K, Tiffany HL, Murphy PM et al. CXCL12 signaling is independent of Jak2 and Jak3. J Biol Chem 2005; 280: 17408\u201317414.","journal-title":"J Biol Chem"},{"key":"BFcmi201647_CR39","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1600-0854.2007.00700.x","volume":"9","author":"T Yoshida","year":"2008","unstructured":"Yoshida T, Kawano Y, Sato K, Ando Y, Aoki J, Miura Y et al. A CD63 mutant inhibits T-cell tropic human immunodeficiency virus type 1 entry by disrupting CXCR4 trafficking to the plasma membrane. Traffic 2008; 9: 540\u2013558.","journal-title":"Traffic"},{"key":"BFcmi201647_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1348-0421.2009.00167.x","volume":"53","author":"T Yoshida","year":"2009","unstructured":"Yoshida T, Ebina H, Koyanagi Y . N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4. Microbiol Immunol 2009; 53: 629\u2013635.","journal-title":"Microbiol Immunol"},{"key":"BFcmi201647_CR41","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.4049\/jimmunol.1103302","volume":"188","author":"TT Zhang","year":"2012","unstructured":"Zhang TT, Makondo KJ, Marshall AJ . p110delta phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression. J Immunol 2012; 188: 3700\u20133708.","journal-title":"J Immunol"},{"key":"BFcmi201647_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/10799890903241824","volume":"29","author":"DA Glauser","year":"2009","unstructured":"Glauser DA, Schlegel W . The FoxO\/Bcl-6\/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic beta-cells. J Recept Signal Transduct Res 2009; 29: 293\u2013298.","journal-title":"J Recept Signal Transduct Res"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201647","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cmi.2016.47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:06:41Z","timestamp":1672744001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFcmi201647"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2016.47","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,26]]},"assertion":[{"value":"25 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}